These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 35582345)

  • 1. Role of Asymptomatic COVID-19 Cases in Viral Transmission: Findings From a Hierarchical Community Contact Network Model.
    Luo T; Cao Z; Wang Y; Zeng D; Zhang Q
    IEEE Trans Autom Sci Eng; 2022 Apr; 19(2):576-585. PubMed ID: 35582345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological characteristics and transmission dynamics of the COVID-19 outbreak in Hohhot, China: a time-varying SQEIAHR model analysis.
    Ma Y; Xu S; Luo Y; Qin Y; Li J; Lei L; He L; Wang T; Yu H; Xie J
    Front Public Health; 2023; 11():1175869. PubMed ID: 37415698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk estimation and prediction of the transmission of coronavirus disease-2019 (COVID-19) in the mainland of China excluding Hubei province.
    Wan H; Cui JA; Yang GJ
    Infect Dis Poverty; 2020 Aug; 9(1):116. PubMed ID: 32831142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study.
    Jing QL; Liu MJ; Zhang ZB; Fang LQ; Yuan J; Zhang AR; Dean NE; Luo L; Ma MM; Longini I; Kenah E; Lu Y; Ma Y; Jalali N; Yang ZC; Yang Y
    Lancet Infect Dis; 2020 Oct; 20(10):1141-1150. PubMed ID: 32562601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the emergency response strategies and measures on the epidemic of COVID-19 in Shenzhen, China].
    Zou X; Wu YS; Liu XJ; Huang SL; He JF; Zhao J; Wu N; Zhang RL; Mei SJ; Liu PY; Zhang Z; Shi XL; Lyu X; Wei L; Ma QS; Lu JH; Li Y; Feng TJ; Peng CQ; Zhang SX; Xia JJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Aug; 41(8):1225-1230. PubMed ID: 32340094
    [No Abstract]   [Full Text] [Related]  

  • 6. A prospect on the use of antiviral drugs to control local outbreaks of COVID-19.
    Torneri A; Libin P; Vanderlocht J; Vandamme AM; Neyts J; Hens N
    BMC Med; 2020 Jun; 18(1):191. PubMed ID: 32586336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new SEAIRD pandemic prediction model with clinical and epidemiological data analysis on COVID-19 outbreak.
    Liu XX; Fong SJ; Dey N; Crespo RG; Herrera-Viedma E
    Appl Intell (Dordr); 2021; 51(7):4162-4198. PubMed ID: 34764574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of public health interventions against COVID-19: Lessons from the Singapore experience.
    Ansah JP; Matchar DB; Shao Wei SL; Low JG; Pourghaderi AR; Siddiqui FJ; Min TLS; Wei-Yan AC; Ong MEH
    PLoS One; 2021; 16(3):e0248742. PubMed ID: 33784332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring secondary SARS-CoV-2 transmission from asymptomatic cases using contact tracing data.
    Nakajo K; Nishiura H
    Theor Biol Med Model; 2021 Jul; 18(1):12. PubMed ID: 34271962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating effects of intervention measures on COVID-19 outbreak in Wuhan taking account of improving diagnostic capabilities using a modelling approach.
    Liang J; Yuan HY; Wu L; Pfeiffer DU
    BMC Infect Dis; 2021 May; 21(1):424. PubMed ID: 33952194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical modeling and optimal intervention strategies of the COVID-19 outbreak.
    Mondal J; Khajanchi S
    Nonlinear Dyn; 2022; 109(1):177-202. PubMed ID: 35125654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of COVID-19 transmission control in Wenzhou using a modified SEIR model.
    Li W; Gong J; Zhou J; Zhang L; Wang D; Li J; Shi C; Fan H
    Epidemiol Infect; 2021 Jan; 149():e2. PubMed ID: 33413715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All-People-Test-Based Methods for COVID-19 Infectious Disease Dynamics Simulation Model: Towards Citywide COVID Testing.
    Liu XX; Yang J; Fong S; Dey N; Millham RC; Fiaidhi J
    Int J Environ Res Public Health; 2022 Sep; 19(17):. PubMed ID: 36078679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exit strategies: optimising feasible surveillance for detection, elimination, and ongoing prevention of COVID-19 community transmission.
    Lokuge K; Banks E; Davis S; Roberts L; Street T; O'Donovan D; Caleo G; Glass K
    BMC Med; 2021 Feb; 19(1):50. PubMed ID: 33596902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.
    Ryu S; Ali ST; Noh E; Kim D; Lau EHY; Cowling BJ
    BMC Infect Dis; 2021 May; 21(1):485. PubMed ID: 34039296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualizing the invisible: The effect of asymptomatic transmission on the outbreak dynamics of COVID-19.
    Peirlinck M; Linka K; Sahli Costabal F; Bhattacharya J; Bendavid E; Ioannidis JPA; Kuhl E
    Comput Methods Appl Mech Eng; 2020 Dec; 372():113410. PubMed ID: 33518823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus disease 2019 epidemic prediction in Shanghai under the "dynamic zero-COVID policy" using time-dependent SEAIQR model.
    Ma Y; Xu S; An Q; Qin M; Li S; Lu K; Li J; Lei L; He L; Yu H; Xie J
    J Biosaf Biosecur; 2022 Dec; 4(2):105-113. PubMed ID: 35756701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling outbreaks of COVID-19 in China: The impact of vaccination and other control measures on curbing the epidemic.
    Zha W; Ni H; He Y; Kuang W; Zhao J; Fu L; Dai H; Lv Y; Zhou N; Yang X
    Hum Vaccin Immunother; 2024 Dec; 20(1):2338953. PubMed ID: 38658178
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.